Lengvári I - Search Results

1

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Reglodi D, Fábián Z, Tamás A, Lubics A, Szeberényi J, Alexy T, Tóth K, Márton Z, Borsiczky B, Rõth E, Szalontay L, Lengvári I. Reglodi D, et al. Among authors: lengvari i. Regul Pept. 2004 Dec 15;123(1-3):51-9. doi: 10.1016/j.regpep.2004.05.012. Regul Pept. 2004. PMID: 15518893

2

Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.

Tamás A, Reglõdi D, Szántó Z, Borsiczky B, Németh J, Lengvári I. Tamás A, et al. Among authors: lengvari i. Neuro Endocrinol Lett. 2002 Jun;23(3):249-54. Neuro Endocrinol Lett. 2002. PMID: 12080287

3

PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina.

Rábl K, Reglodi D, Bánvölgyi T, Somogyvári-Vigh A, Lengvári I, Gábriel R, Arimura A. Rábl K, et al. Among authors: lengvari i. Regul Pept. 2002 Nov 15;109(1-3):71-4. doi: 10.1016/s0167-0115(02)00189-1. Regul Pept. 2002. PMID: 12409217

4

The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

Reglodi D, Kiss P, Tamás A, Lengvári I. Reglodi D, et al. Among authors: lengvari i. Behav Brain Res. 2003 Mar 18;140(1-2):131-9. doi: 10.1016/s0166-4328(02)00289-9. Behav Brain Res. 2003. PMID: 12644286

5

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Among authors: lengvari i. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

6

Development of the circadian melatonin rhythm and the effect of PACAP on melatonin release in the embryonic chicken pineal gland. An in vitro study.

Faluhelyi N, Reglodi D, Lengvári I, Csernus V. Faluhelyi N, et al. Among authors: lengvari i. Regul Pept. 2004 Dec 15;123(1-3):23-8. doi: 10.1016/j.regpep.2004.05.009. Regul Pept. 2004. PMID: 15518889

7

Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.

Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Farkas O, et al. Among authors: lengvari i. Regul Pept. 2004 Dec 15;123(1-3):69-75. doi: 10.1016/j.regpep.2004.05.014. Regul Pept. 2004. PMID: 15518895

8

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Reglodi D, Tamás A, Lubics A, Szalontay L, Lengvári I. Reglodi D, et al. Among authors: lengvari i. Regul Pept. 2004 Dec 15;123(1-3):85-94. doi: 10.1016/j.regpep.2004.05.016. Regul Pept. 2004. PMID: 15518897

9

Effects of in ovo treatment with PACAP antagonist on general activity, motor and social behavior of chickens.

Hollósy T, Józsa R, Jakab B, Németh J, Lengvári I, Reglodi D. Hollósy T, et al. Among authors: lengvari i. Regul Pept. 2004 Dec 15;123(1-3):99-106. doi: 10.1016/j.regpep.2004.05.018. Regul Pept. 2004. PMID: 15518899

10

Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.

Tamás A, Gábriel R, Rácz B, Dénes V, Kiss P, Lubics A, Lengvári I, Reglodi D. Tamás A, et al. Among authors: lengvari i. Neurosci Lett. 2004 Nov 30;372(1-2):110-3. doi: 10.1016/j.neulet.2004.09.021. Neurosci Lett. 2004. PMID: 15531098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters